Curriculum vitae
Dr. med. (I) Jan-Dirk Fauteck
Personal data
Date and place of birth
09th May, 1962, Lemgo, Nordrhein-Westfalen, Germany
Citizenship
German
Languages
German, Italian, English (written and spoken)
Education
2005
Diploma of preventive and anti-aging medicine board certificated by ESAAM (European society of anti aging medicine)
1997
Qualification as specialist in human anatomy, histology and embryology; University Münster
1993
German recognition of the Italian board certification as medical
doctor (Dr. med)
1992
Italian board certification as medical doctor (vote: maximum)
1992
Italian medical degree as “Dottore della medicina et chirugia” (MD) Institute of Pharmacology, University of Milan, Italy (vote: summa cum laude)
1982 – 1992
Study of Medicine, University of Milan, Italy
1982
High-school diploma from the Gymnasium Leopoldinum 2, Detmold, Germany (vote: maximum)
Actual professional activities
Since 2018
Head of R&D of “AG Chroning 432”, a German based society involved within the research of new products against circadian rhythms disorder
Since 2011
CEO of “ea³m”, the European academy of preventive and anti- aging medicine
Since 2006
CEO of “A.M.C.-Lodi srl”, an Italian consulting agency for preventive and anti-aging medicine as well as sales office for different companies.
Since 2002
CEO of “FIS international GbR”, a private Germany consulting agency for “pharmaceutical/galenic scouting” and clinical development
Past professional activities
2016 – 2018
Associate private docent at the international Jacobs University Bremen for “basics of anatomy”.
2001 – 2007
General Manager of PROVERUM GmbH, a clinical research organization, located at Münster, Germany; medical affairs
1997 – 2000
Project Manager at an international pharmaceutical company
(Jenapharm GmbH & Co. KG, Germany)
1993 – 1997
Post-doctorate fellowship, Institute of Anatomy, University of Münster; Germany, Head: Prof. W. Wittkowski
1989 – 1992
Research Assistant, Institute of Pharmacology, University of Milan, Italy, Head: Prof. F. Fraschini
Other professional/scientific activities
Since 2016
Secretary and founding member of “interchron” = international
forum of chronobiology
Since 2011
CEO and founding member of “EA³M” = European Academy of
preventive and anti aging medicine, Kalletal Germany
Publications
by the numbers
Printed Books
7
E- Books
58
Original Publications
25+
Communications at national
and international congresses
100+
Scientific areas of interests
and consulting activities
since 2011
CEO and head of the scientific board of the European academy of
preventive and Anti Aging medicine (EA³M)
since 2009
Member of the scientific board of the German Society of Anti Aging
Medicine (GSAAM München)
2004 – 2009
Head of Education Board of the European Society of Anti Aging Medicine
(ESAAM Vienna)
since 2000
Consultant for new drug delivery forms for different pharmaceutical and
non-pharmaceutical companies
since 1999
Specialist for “ preventive and anti aging medicine”
since 1997
Expert for “Idolamines and Aging”
1997 – 2000
Project Manager of “VLP – a new drug delivery system”
Project Manager of “aging male”
Study Manager of “Testosterone replacement therapy”
1996 – 1997
Focal Epilepsy in humans:
Head of an interdisciplinary research project with the aim to evaluate the
use of new anti-epileptic drugs.
Pathophysiology and development of new therapeutic approaches for
children with severe sleep disorders
1993 – 1995
The pars tuberalis as “Zeitgeber” of the endocrine system
Phytopharmaceuticals and their role for the biorhythm in humans with
special regard to “Valeriana officinalis”
Gaba-ergic and mt1- membrane receptors in the human CNS:
distribution and function in the human tissue
1989 – 1993
Melatonin receptors in the CNS:
The CNS of the rabbit as model to develop basic data and to evaluate the
role of melatonin application in humans (thesis for medical degree)
Experiences in selected clinical trials for medical devices and pharmaceuticals
Clinical investigator/core clinician (LKP) for the following studies:
- melatonin dose finding study phase I (Nov 97 – Nov 98)
- TU injections proof of concept, medical device (Sep 98 – Jan 99)
- TU patch, proof of concept, medical device (Dec. 98- Dec 99)
- DHEA-HRT study, phase I (May 98 – Jan 99)
- DHEA-HRT study, phase II (Nov 99 – Sep 00)
- DHEA dose finding study, phase I (Sep 01 – Feb 02)
- DHEA dose finding study, phase I (Nov 02 – Apr 03)
- TU injection study, phase III, medical device and pharmaceutical product study (Jun 98 – Feb 02)
- TU patch dose finding stud, phase I, medical device and pharmaceutical product study (Jan 03 – Aug 03)
- psoriasis efficacy study, phase II, (Jul 03 – Sep 03)
- Ethanol/Isopropanol kinetic study, phase I (Nov 03- Dec 03)
- Anesthesin® efficacy study , phase III (Nov 03 – Mar 04)
- 5-ALA fluorescence study, phase I (Feb. 04 – May 04)
- Anaesthesulf® efficacy study, phase III (Nov 03 – Apr 04)
- Anaesthesulf® Epicutan study phase I (May 04 – Jun 04)
- EKC Epicutan study, phase I (May 04 – Jun 04)
- Arnica Epicutan study, phase I (Aug 04 – Sep 04)
- Anaesthesulf® Challenge Test phase I (Jul 04 – Sep 04)
- 5-ALA pharmacokinetic study, phase I (Apr 05 – May 05)
- Felbinac Challenge Test phase I (July 05 – Sep 05)
- 5-FU-AK study, phase II (Jan 06 – March 06)
- IDEA-Study, phase II (Dec-05- Oct 06)
- ABC study, medical device study (Feb. 06 – Mar 07)
- TIPI study, phase II (Oct 05- Oct 07)
- IVF study, phase III (Sep. 2006 – Dec 07)
- TIPI study, phase III (Jan 06 – Dec 08)
